DE3766343D1 - Ibuprofen und aluminiumhydroxid enthaltendes arzneimittel. - Google Patents

Ibuprofen und aluminiumhydroxid enthaltendes arzneimittel.

Info

Publication number
DE3766343D1
DE3766343D1 DE8787307943T DE3766343T DE3766343D1 DE 3766343 D1 DE3766343 D1 DE 3766343D1 DE 8787307943 T DE8787307943 T DE 8787307943T DE 3766343 T DE3766343 T DE 3766343T DE 3766343 D1 DE3766343 D1 DE 3766343D1
Authority
DE
Germany
Prior art keywords
ibuprofen
aluminum hydroxide
product containing
aluminium hydroxide
medicinal product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787307943T
Other languages
English (en)
Inventor
Mahendra Govind Pankhania
Colin John Lewis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boots Co PLC
Original Assignee
Boots Co PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co PLC filed Critical Boots Co PLC
Application granted granted Critical
Publication of DE3766343D1 publication Critical patent/DE3766343D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE8787307943T 1986-10-01 1987-09-09 Ibuprofen und aluminiumhydroxid enthaltendes arzneimittel. Expired - Fee Related DE3766343D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868623557A GB8623557D0 (en) 1986-10-01 1986-10-01 Therapeutic agents

Publications (1)

Publication Number Publication Date
DE3766343D1 true DE3766343D1 (de) 1991-01-03

Family

ID=10605072

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787307943T Expired - Fee Related DE3766343D1 (de) 1986-10-01 1987-09-09 Ibuprofen und aluminiumhydroxid enthaltendes arzneimittel.

Country Status (16)

Country Link
US (1) US4831058A (de)
EP (1) EP0264187B1 (de)
JP (1) JPS63101321A (de)
KR (1) KR950009090B1 (de)
AT (1) ATE58471T1 (de)
AU (1) AU594607B2 (de)
CA (1) CA1306686C (de)
DE (1) DE3766343D1 (de)
DK (1) DK503687A (de)
ES (1) ES2031904T3 (de)
GB (1) GB8623557D0 (de)
GR (1) GR3001284T3 (de)
IE (1) IE61062B1 (de)
NZ (1) NZ221962A (de)
PT (1) PT85829B (de)
ZA (1) ZA876731B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3669103D1 (de) * 1986-11-14 1990-04-05 Puetter Medice Chem Pharm Ibuprofen enthaltendes arzneimittel.
IT1226549B (it) * 1988-07-12 1991-01-24 Resa Farma Composizioni farmaceutiche ad attivita' analgesica ed antiinfiammatoria per uso orale, dotate di ottima palatabilita' ed esenti da effetti irritanti sulle mucose.
US4916161A (en) * 1988-10-25 1990-04-10 Bristol-Myers Squibb Taste-masking pharmaceutical agents
DE3938227C1 (en) * 1989-11-17 1991-05-02 Dolorgiet Gmbh & Co Kg, 5205 St Augustin, De Oral antiinflammatory and analgetic pharmaceutical compsn. - comprises magnesium ibuprofen dissolved in mixt. of water, propane-1,2-diol and glycerol
DK0587744T3 (da) * 1991-05-28 2003-10-20 Mcneil Ppc Inc Tygbar sammensætning til frigørelse af et lægemiddel
US5380535A (en) * 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
US5605930A (en) * 1991-10-21 1997-02-25 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
US5409709A (en) * 1991-11-29 1995-04-25 Lion Corporation Antipyretic analgesic preparation containing ibuprofen
US5288507A (en) * 1992-07-29 1994-02-22 Merck & Co., Inc. Ibuprofen antacid combinations
AU699192B2 (en) * 1993-08-13 1998-11-26 Bayer Corporation Hydrolyzed gelatin as a flavor enhancer in a chewable tablet
EP0812589B1 (de) * 1993-12-10 2000-08-16 Fujisawa Pharmaceutical Co., Ltd. Kombiniertes antipyretisches und analgetisches arzneimittel
IT1270239B (it) * 1994-06-17 1997-04-29 Zambon Spa Composizione farmaceutica solida contenente acido (s)-2-(4- isobutilfenil) propionico come principio attivo
US5639475A (en) * 1995-02-03 1997-06-17 Eurand America, Incorporated Effervescent microcapsules
DE19529862A1 (de) * 1995-08-14 1997-02-20 Rhone Poulenc Rorer Gmbh Pharmazeutische, oral anwendbare Zubereitung
GB9625589D0 (en) 1996-12-10 1997-01-29 Boots Co Plc Therapeutic agents
US6376481B2 (en) * 1998-09-02 2002-04-23 Mcneil-Ppc, Inc. Sterol esters in tableted solid dosage forms
ES2601855T3 (es) * 1998-11-25 2017-02-16 Cima Labs Inc. Comprimido de liberación rápida con núcleo recubierto que contiene el fármaco y capa circundante de enmascaramiento del sabor
US6740341B1 (en) 1998-11-25 2004-05-25 Cima Labs Inc. Taste masking rapid release coating system
IE990159A1 (en) * 1999-02-26 2000-09-20 Fuisz Internat Ltd Storage Stable Amoxycillin and Clavulanate Suspension Composition.
JP5519890B2 (ja) * 2001-02-28 2014-06-11 エスエス製薬株式会社 経口用イブプロフェン製剤
ES2323264T3 (es) * 2001-08-01 2009-07-10 Novartis Ag Composicion para enmascaramiento del sabor.
AU2003220058B2 (en) * 2002-03-12 2008-05-01 Toyama Chemical Company Limited Palatable oral suspension and method
FR2850275B1 (fr) 2003-01-24 2005-04-08 Scherer Technologies Inc R P Capsules molles a macher contenant une substance active a gout masque
CA2620219A1 (en) * 2005-11-02 2007-05-18 Teikoku Pharma Usa, Inc. Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same
EP2158913A1 (de) * 2008-08-25 2010-03-03 Ratiopharm GmbH Pharmazeutische Zusammensetzung mit N-[3-chlor-4-(3-fluorophenyl)methoxy)phenyl)6-(5(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furyl)-4-chinazolinamin
JP5740896B2 (ja) * 2009-10-27 2015-07-01 ライオン株式会社 解熱鎮痛組成物
JP6140570B2 (ja) * 2013-08-13 2017-05-31 ライオン株式会社 イブプロフェン含有錠剤及びその製造方法
US10821073B1 (en) 2013-09-30 2020-11-03 Make Ideas, LLC Edible animal medicine container
US9498433B1 (en) * 2013-09-30 2016-11-22 Make Ideas, LLC Edible animal medicine container
JP6877923B2 (ja) * 2016-09-06 2021-05-26 ライオン株式会社 内服用半固形製剤及びその製造方法
US11503806B1 (en) 2018-06-12 2022-11-22 Make Ideas Llc Dog dental device with brushes extending through compressible outer shell
BR112021009468A2 (pt) * 2018-11-16 2021-08-10 Ssp Co., Ltd. formulação farmacêutica oral contendo ibuprofeno

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636200A (en) * 1969-06-09 1972-01-18 Hoffmann La Roche Pharmaceutical suspension
DE2213704C3 (de) * 1971-03-22 1975-06-12 Teikoku Hormone Manufacturing Co. Ltd., Tokio 07.03.72 Japan 22767-72 Verfahren zur Herstellung von Aluminiumsalzen von Carboxylgruppen enthaltenden, pharmazeutisch wirksamen Verbindungen
GB1435892A (en) * 1972-07-04 1976-05-19 Beecham Group Ltd Aluminium complexes of guaiphenesin
GB1451541A (en) * 1974-02-16 1976-10-06 Lilly Co Eli Aluminum salts of substituted phenyl-alkanoic acids and pharma ceutical suspensions prepared therefrom core-sampling device for obtaining a core sample from a loose
CA1062721A (en) * 1975-12-15 1979-09-18 Anthony A. Sinkula Propionic acid derivatives
US4145440A (en) * 1977-08-18 1979-03-20 The Upjohn Company Liquid suspension of an aluminum salt of ibuprofen
US4361580A (en) * 1980-06-20 1982-11-30 The Upjohn Manufacturing Company Aluminum ibuprofen pharmaceutical suspensions
SE8103843L (sv) * 1981-06-18 1982-12-19 Astra Laekemedel Ab Farmaceutisk mixtur
EP0094116A3 (de) * 1982-05-06 1984-08-01 The Procter & Gamble Company Therapeutische Granulate
IT1175941B (it) * 1984-02-16 1987-08-12 Stabil Bioterapico Farmachim Sali d'alluminio mono, bi e trisostituiti degli acidi aril-alcanoici e composizioni farmaceutiche che li contengono
AT385894B (de) * 1985-10-04 1988-05-25 Basem Dr Nashef Schlauchfoermige sonde
US4753800A (en) * 1985-10-04 1988-06-28 Warner-Lambert Company Medicament adsorbates and their preparation
US4716033A (en) * 1986-03-27 1987-12-29 Warner-Lambert Company Medicament adsorbates with surfactant and their preparation

Also Published As

Publication number Publication date
AU594607B2 (en) 1990-03-08
GR3001284T3 (en) 1992-08-26
PT85829A (en) 1987-10-01
EP0264187B1 (de) 1990-11-22
EP0264187A1 (de) 1988-04-20
KR880004807A (ko) 1988-06-27
ES2031904T3 (es) 1993-01-01
GB8623557D0 (en) 1986-11-05
IE61062B1 (en) 1994-09-21
NZ221962A (en) 1990-03-27
AU7921887A (en) 1988-04-14
JPS63101321A (ja) 1988-05-06
CA1306686C (en) 1992-08-25
ZA876731B (en) 1988-03-14
DK503687D0 (da) 1987-09-25
PT85829B (pt) 1990-07-31
KR950009090B1 (ko) 1995-08-14
IE872400L (en) 1989-03-08
US4831058A (en) 1989-05-16
ATE58471T1 (de) 1990-12-15
DK503687A (da) 1988-04-02

Similar Documents

Publication Publication Date Title
ATE58471T1 (de) Ibuprofen und aluminiumhydroxid enthaltendes arzneimittel.
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
AU645555B2 (en) Improvements in or relating to the treatment of gastrointestinal disorders
CA2024916A1 (en) Respiratory disorder medicaments comprising salmeterol and fluticasone propionate
EP0221041A3 (de) Benzimidazolderivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
TR199500856A2 (tr) Nefesle ice cekilerek alinan farmasötik bilesim.
CA2093806A1 (en) Method of treating or preventing type 1 diabetes by oral administration of insulin
CA2004239A1 (en) Use of acetyl d-carnitine in the therapeutic treatment of glaucoma, and pharmaceutical compositions useful in such treatment
ES2006649A6 (es) Una composicion para depositarse sobre la superficie de un granulo de un producto farmaceutico y procedimiento para la obtencion de la misma.
CA2024872A1 (en) Medicaments
HU9400430D0 (en) New pyrazine derivatives, their preparation and pharmaceutical compositions containing them
CA2136404A1 (fr) Composition solide mucoadhesive, therapeutique ou hygienique, pour administration par application sur la muqueuse buccale ou nasale
GR890100833A (en) Process for the preparation of a compound with gastric inhibitopy effect
GB1487334A (en) Pharmaceutical preparations comprising lisuride and/or physiologically tolerable salts thereof
CA2078869A1 (en) Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use
ES2064104T3 (es) Procedimiento de preparacion de composiciones farmaceuticas del tipo de liberacion prolongada destinadas a la administracion por via oral.
GB1446237A (en) Pharmaceutical preparations containing pyrazolones
IL57513A0 (en) 1,3-diaminopropan-2-ol derivatives,their preparation and pharmaceutical compositions containing them
DE69325531D1 (de) Oral anzuwendendes Arzneimittel bestehend aus Ibuprofen
DE3786168D1 (de) Verwendung von para-aminobenzoesaeure zur herstellung eines arzneimittels zur bekaempfung von photoallergien.
JPS57114518A (en) Hypotensive agent

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee